Share articleAs U.S. lawmakers debate issues around health care for transgender youth, it’s been difficult to determine the ...

Researchers say among those with private insurance, not one transgender person under 12 was prescribed gender-affirming hormones. “There’s not some massive wave of folks accessing care,” the report's ...

The study, published in JAMA Pediatrics on Monday, looked at private insurance claims representing over 5 million patients in ...

A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for ...

Fewer than 1 in 1,000 U.S. adolescents with commercial insurance received gender-affirming medications -- puberty blockers or ...

Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, ...

The findings, published in JAMA Pediatrics, suggest that fewer than 0.1% of all youth in the database received these medications. Only 926 adolescents were prescribed puberty blockers, and 1,927 ...

I am still enough of an institutionalist that it pains me to hear Supreme Court justices embarrassing ... that urged caution in the provision of puberty blockers to teens, Alito engaged in a ...

Experts believe the Supreme Court’s decision in the case could ... who admitted to not publicizing a study that found puberty blockers didn't lead to mental health improvements, for fear of ...